Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 08, 2018

SELL
$60.85 - $83.98 $202,022 - $278,813
-3,320 Closed
0 $0
Q1 2018

May 11, 2018

BUY
$83.06 - $100.98 $36,131 - $43,926
435 Added 15.08%
3,320 $277 Million
Q4 2017

Feb 07, 2018

BUY
$93.56 - $116.6 $269,920 - $336,391
2,885
2,885 $273 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Ipg Investment Advisors LLC Portfolio

Follow Ipg Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ipg Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ipg Investment Advisors LLC with notifications on news.